Spontaneous cholecysto- and hepatolithiasis in Mdr2 −/− mice: A model for low phospholipid-associated cholelithiasis†
Open Access
- 5 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 39 (1), 117-128
- https://doi.org/10.1002/hep.20022
Abstract
Previously, we identified needle-like and filamentous, putatively “anhydrous” cholesterol crystallization in vitro at very low phospholipid concentrations in model and native biles. Our aim now was to address whether spontaneous gallstone formation occurs in Mdr2 (Abcb4) knockout mice that are characterized by phospholipid-deficient bile. Biliary phenotypes and cholesterol crystallization sequences in fresh gallbladder biles and non-fixed liver sections were determined by direct and polarizing light microscopy. The physical chemical nature and composition of crystals and stones were determined by sucrose density centrifugation and before mass and infrared spectroscopy. Gallbladder biles of Mdr2 −/− mice precipitate needle-like cholesterol crystals at 12 weeks of age on chow. After 15 weeks, more than 50% of Mdr2 −/− mice develop gallbladder stones, with female mice displaying a markedly higher gallstone-susceptibility. Although gallbladder biles of Mdr2 −/− mice contain only traces (≤ 1.1 mM) of phospholipid and cholesterol, they become supersaturated with cholesterol and plot in the left 2-phase zone of the ternary phase diagram, consistent with “anhydrous” cholesterol crystallization. Furthermore, more than 40% of adult female Mdr2 −/− mice show intra- and extrahepatic bile duct stones. In conclusion, spontaneous gallstone formation is a new consistent feature of the Mdr2 −/− phenotype. The Mdr2 −/− mouse is therefore a model for low phospholipid-associated cholelithiasis recently described in humans with a dysfunctional mutation in the orthologous ABCB4 gene. The mouse model supports the concept that this gene is a monogenic risk factor for cholesterol gallstones and a target for novel therapeutic strategies. (Hepatology 2004;39:117-128.)Keywords
This publication has 52 references indexed in Scilit:
- Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy.Journal of Clinical Investigation, 1997
- Monitoring cholesterol crystallization from lithogenic model bile by time-lapse density gradient ultracentrifugationJournal of Hepatology, 1997
- The role of bile salt composition in liver pathology of mdr2 (−/−) mice: differences between males and femalesJournal of Hepatology, 1997
- Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein geneGastroenterology, 1996
- Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.Journal of Clinical Investigation, 1995
- Cholesterol crystallization from a dilute bile salt-rich model bileJournal of Crystal Growth, 1994
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseaseCell, 1993
- Lincomycin treatment of guinea pigs causes formation of pigmented phosphate containing gallbladder sludge and stonesJournal of Hepatology, 1989
- Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugatesBiochemistry, 1981
- Biliary lipids, bile acids and gallstone formation in hypovitaminotic C guinea-pigsBritish Journal of Nutrition, 1978